Rabacfosadine Uses, Dosage, Side Effects and more
Rabacfosadine has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin's Lymphoma, and Chronic Lymphocytic Leukemia.
| Trade Name | Rabacfosadine |
| Generic | Rabacfosadine |
| Rabacfosadine Other Names | Rabacfosadine |
| Type | |
| Formula | C21H35N8O6P |
| Weight | Average: 526.535 Monoisotopic: 526.241717877 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
